カテゴリ： 世界, 医療/バイオ, Market Monitor Global

経皮・経粘膜ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム

■ 英語タイトル：Transdermal & Transmucosal Drug Delivery System Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8716）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8716
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：79
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[経皮・経粘膜ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の経皮・経粘膜ドラッグデリバリーシステム市場規模と予測を収録しています。・世界の経皮・経粘膜ドラッグデリバリーシステム市場：売上、2018年-2023年、2024年-2029年
・世界の経皮・経粘膜ドラッグデリバリーシステム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経皮・経粘膜ドラッグデリバリーシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経皮ドラッグデリバリーシステム」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

経皮・経粘膜ドラッグデリバリーシステムのグローバル主要企業は、3M、 Antares Pharma、 Aveva Drug Delivery Systems、 Corium International、 DURECT、 Pantec Biosolutions、 Tapemark、 Tesa Labtec、 Mylan、 Teva、 Zosano Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、経皮・経粘膜ドラッグデリバリーシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の経皮・経粘膜ドラッグデリバリーシステム市場：タイプ別、2018年-2023年、2024年-2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場：タイプ別市場シェア、2022年
・経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム

世界の経皮・経粘膜ドラッグデリバリーシステム市場：用途別、2018年-2023年、2024年-2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の経皮・経粘膜ドラッグデリバリーシステム市場：地域・国別、2018年-2023年、2024年-2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル売上、2018年-2023年
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル売上シェア、2022年
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル販売量、2018年-2023年
・主要企業における経皮・経粘膜ドラッグデリバリーシステムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
3M、 Antares Pharma、 Aveva Drug Delivery Systems、 Corium International、 DURECT、 Pantec Biosolutions、 Tapemark、 Tesa Labtec、 Mylan、 Teva、 Zosano Pharma

*************************************************************

・調査・分析レポートの概要
経皮・経粘膜ドラッグデリバリーシステム市場の定義
市場セグメント
世界の経皮・経粘膜ドラッグデリバリーシステム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経皮・経粘膜ドラッグデリバリーシステム市場規模
世界の経皮・経粘膜ドラッグデリバリーシステム市場規模：2022年 VS 2029年
世界の経皮・経粘膜ドラッグデリバリーシステム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経皮・経粘膜ドラッグデリバリーシステムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経皮・経粘膜ドラッグデリバリーシステム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム
経皮・経粘膜ドラッグデリバリーシステムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
経皮・経粘膜ドラッグデリバリーシステムの用途別グローバル売上・予測

・地域別市場分析
地域別経皮・経粘膜ドラッグデリバリーシステム市場規模 2022年と2029年
地域別経皮・経粘膜ドラッグデリバリーシステム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
3M、 Antares Pharma、 Aveva Drug Delivery Systems、 Corium International、 DURECT、 Pantec Biosolutions、 Tapemark、 Tesa Labtec、 Mylan、 Teva、 Zosano Pharma
...

Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products. 
This report aims to provide a comprehensive presentation of the global market for Transdermal & Transmucosal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal & Transmucosal Drug Delivery System. This report contains market size and forecasts of Transdermal & Transmucosal Drug Delivery System in global, including the following market information:
Global Transdermal & Transmucosal Drug Delivery System Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Transdermal & Transmucosal Drug Delivery System Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Transdermal & Transmucosal Drug Delivery System companies in 2022 (%)
The global Transdermal & Transmucosal Drug Delivery System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Transdermal Drug Delivery System Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transdermal & Transmucosal Drug Delivery System include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec and Mylan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal & Transmucosal Drug Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal & Transmucosal Drug Delivery System Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Transdermal & Transmucosal Drug Delivery System Market Segment Percentages, by Type, 2022 (%)
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Global Transdermal & Transmucosal Drug Delivery System Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Transdermal & Transmucosal Drug Delivery System Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Transdermal & Transmucosal Drug Delivery System Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Transdermal & Transmucosal Drug Delivery System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal & Transmucosal Drug Delivery System revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Transdermal & Transmucosal Drug Delivery System revenues share in global market, 2022 (%)
Key companies Transdermal & Transmucosal Drug Delivery System sales in global market, 2018-2023 (Estimated), (Units)
Key companies Transdermal & Transmucosal Drug Delivery System sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal & Transmucosal Drug Delivery System, market overview.
Chapter 2: Global Transdermal & Transmucosal Drug Delivery System market size in revenue and volume.
Chapter 3: Detailed analysis of Transdermal & Transmucosal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal & Transmucosal Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transdermal & Transmucosal Drug Delivery System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Transdermal & Transmucosal Drug Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal & Transmucosal Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal & Transmucosal Drug Delivery System Overall Market Size
2.1 Global Transdermal & Transmucosal Drug Delivery System Market Size: 2022 VS 2029
2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Transdermal & Transmucosal Drug Delivery System Sales: 2018-2029
3 Company Landscape
3.1 Top Transdermal & Transmucosal Drug Delivery System Players in Global Market
3.2 Top Global Transdermal & Transmucosal Drug Delivery System Companies Ranked by Revenue
3.3 Global Transdermal & Transmucosal Drug Delivery System Revenue by Companies
3.4 Global Transdermal & Transmucosal Drug Delivery System Sales by Companies
3.5 Global Transdermal & Transmucosal Drug Delivery System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Transdermal & Transmucosal Drug Delivery System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Transdermal & Transmucosal Drug Delivery System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal & Transmucosal Drug Delivery System Players in Global Market
3.8.1 List of Global Tier 1 Transdermal & Transmucosal Drug Delivery System Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal & Transmucosal Drug Delivery System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Transdermal & Transmucosal Drug Delivery System Market Size Markets, 2022 & 2029
4.1.2 Transdermal Drug Delivery System
4.1.3 Transmucosal Drug Delivery System
4.2 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue & Forecasts
4.2.1 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2023
4.2.2 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2024-2029
4.2.3 By Type – Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
4.3 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales & Forecasts
4.3.1 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales, 2018-2023
4.3.2 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales, 2024-2029
4.3.3 By Type – Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
4.4 By Type – Global Transdermal & Transmucosal Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Transdermal & Transmucosal Drug Delivery System Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue & Forecasts
5.2.1 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2023
5.2.2 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2024-2029
5.2.3 By Application – Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
5.3 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales & Forecasts
5.3.1 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales, 2018-2023
5.3.2 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales, 2024-2029
5.3.3 By Application – Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
5.4 By Application – Global Transdermal & Transmucosal Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Transdermal & Transmucosal Drug Delivery System Market Size, 2022 & 2029
6.2 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue & Forecasts
6.2.1 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2023
6.2.2 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue, 2024-2029
6.2.3 By Region – Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share, 2018-2029
6.3 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales & Forecasts
6.3.1 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales, 2018-2023
6.3.2 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales, 2024-2029
6.3.3 By Region – Global Transdermal & Transmucosal Drug Delivery System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.4.2 By Country – North America Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.4.3 US Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.4.4 Canada Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.4.5 Mexico Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.5.2 By Country – Europe Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.5.3 Germany Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.4 France Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.5 U.K. Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.6 Italy Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.7 Russia Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.8 Nordic Countries Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.5.9 Benelux Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.6.2 By Region – Asia Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.6.3 China Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.4 Japan Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.5 South Korea Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.6 Southeast Asia Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.6.7 India Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.7.2 By Country – South America Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.7.3 Brazil Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.7.4 Argentina Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Transdermal & Transmucosal Drug Delivery System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Transdermal & Transmucosal Drug Delivery System Sales, 2018-2029
6.8.3 Turkey Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8.4 Israel Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8.5 Saudi Arabia Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
6.8.6 UAE Transdermal & Transmucosal Drug Delivery System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.1.4 3M Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 Antares Pharma
7.2.1 Antares Pharma Company Summary
7.2.2 Antares Pharma Business Overview
7.2.3 Antares Pharma Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.2.4 Antares Pharma Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.2.5 Antares Pharma Key News & Latest Developments
7.3 Aveva Drug Delivery Systems
7.3.1 Aveva Drug Delivery Systems Company Summary
7.3.2 Aveva Drug Delivery Systems Business Overview
7.3.3 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.3.4 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.3.5 Aveva Drug Delivery Systems Key News & Latest Developments
7.4 Corium International
7.4.1 Corium International Company Summary
7.4.2 Corium International Business Overview
7.4.3 Corium International Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.4.4 Corium International Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.4.5 Corium International Key News & Latest Developments
7.5 DURECT
7.5.1 DURECT Company Summary
7.5.2 DURECT Business Overview
7.5.3 DURECT Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.5.4 DURECT Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.5.5 DURECT Key News & Latest Developments
7.6 Pantec Biosolutions
7.6.1 Pantec Biosolutions Company Summary
7.6.2 Pantec Biosolutions Business Overview
7.6.3 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.6.4 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.6.5 Pantec Biosolutions Key News & Latest Developments
7.7 Tapemark
7.7.1 Tapemark Company Summary
7.7.2 Tapemark Business Overview
7.7.3 Tapemark Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.7.4 Tapemark Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.7.5 Tapemark Key News & Latest Developments
7.8 Tesa Labtec
7.8.1 Tesa Labtec Company Summary
7.8.2 Tesa Labtec Business Overview
7.8.3 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.8.4 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.8.5 Tesa Labtec Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.9.4 Mylan Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Teva
7.10.1 Teva Company Summary
7.10.2 Teva Business Overview
7.10.3 Teva Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.10.4 Teva Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.10.5 Teva Key News & Latest Developments
7.11 Zosano Pharma
7.11.1 Zosano Pharma Company Summary
7.11.2 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Business Overview
7.11.3 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Major Product Offerings
7.11.4 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Sales and Revenue in Global (2018-2023)
7.11.5 Zosano Pharma Key News & Latest Developments
8 Global Transdermal & Transmucosal Drug Delivery System Production Capacity, Analysis
8.1 Global Transdermal & Transmucosal Drug Delivery System Production Capacity, 2018-2029
8.2 Transdermal & Transmucosal Drug Delivery System Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal & Transmucosal Drug Delivery System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal & Transmucosal Drug Delivery System Supply Chain Analysis
10.1 Transdermal & Transmucosal Drug Delivery System Industry Value Chain
10.2 Transdermal & Transmucosal Drug Delivery System Upstream Market
10.3 Transdermal & Transmucosal Drug Delivery System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal & Transmucosal Drug Delivery System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 薄膜ドラッグデリバリーのグローバル市場展望 2023年-2029年：口腔用薄膜、経皮用フィルム、その他
  • チューインガム用薬物送達装置のグローバル市場展望 2023年-2029年：固体、半固体
  • 筋肉内薬物送達装置のグローバル市場展望 2023年-2029年：分子構造、ポリマー、ゲル、その他
  • スプレー薬物送達装置のグローバル市場展望 2023年-2029年：手持ちネブライザー、気圧噴霧器、超音波ネブライザー
  • 標的薬物送達におけるナノテクノロジーのグローバル市場展望 2023年-2029年：リポソーム医薬品、脂質ナノ粒子医薬品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8716 )"経皮・経粘膜ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：経皮ドラッグデリバリーシステム、経粘膜ドラッグデリバリーシステム" (英文：Transdermal & Transmucosal Drug Delivery System Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。